SKYRX
Live / Applied — First extension granted (statement of use) (as of 16 Oct 2025)
What this means for you
Not registered yet, but its 19 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98509856
- Mark type
- Stylized text
- Filed
- 19 Apr 2024
- Published for opposition
- 18 Feb 2025
- Attorney of record
- Zachary D. Messa
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for treating issues with sexual performance, namely, sildenafil, tadalafil and sertraline; pharmaceutical preparations for improving one's overall health, namely, nicotinamide adenine dinucleotide; pharmaceutical preparations for treating sleep disorders, namely trazodone and hydroxyzine; pharmaceutical preparations for preventing hair loss, namely finasteride; pharmaceutical preparations for weight loss; pharmaceutical preparations in the nature of melatonin to promote sleep; pharmaceutical preparations in the nature of biotin to promote hair growth
- Class 035 — Advertising and business services: Online retail store services featuring pharmaceuticals to promote sexual performance, for one's overall health, and to treat sleep disorders and hair loss
Owner
- VIKING MAN, INC., MIDVALE, UT, US
- VIKING MAN, INC., MIDVALE, UT, US
Prosecution history
- 16 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Oct 2025 — SOU EXTENSION 1 GRANTED
- 15 Oct 2025 — SOU EXTENSION 1 FILED
- 15 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Feb 2025 — PUBLISHED FOR OPPOSITION
- 12 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Jan 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 04 Nov 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 04 Nov 2024 — NON-FINAL ACTION E-MAILED
- 04 Nov 2024 — NON-FINAL ACTION WRITTEN